(Q31003450)

28 June 2017

1 reference

title

Diagnosis and treatment of atypical and anaplastic meningiomas: a review (English)

1 reference

28 June 2017

Ashok Modha

1

1 reference

PubMed ID

16145534

28 June 2017

Philip H Gutin

series ordinal

2

1 reference

PubMed ID

16145534

28 June 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

28 June 2017

1 reference

28 June 2017

57

1 reference

28 June 2017

3

1 reference

28 June 2017

538-50; discussion 538-50

1 reference

MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.

28 June 2017

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Adjuvant combined modality therapy for malignant meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

(1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Local control and overall survival in atypical meningioma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

The effect of radiosurgeryduring management of aggressive meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Hemorrhagic complications in embolization of a meningioma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Meningioma pathology, genetics, and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Non-resectable slow-growing meningiomas treated by hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Atypical and malignant meningiomas: a clinicopathological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Radiotherapy for atypical or malignant intracranial meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Meningioma grading: an analysis of histologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Incidence and clinicopathological features of meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Aggressive meningeal tumors: review of a series

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000170980.47582.A5

10.1227/01.NEU.0000170980.47582.A5

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

16145534